Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia
Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia
复制标题
DOI：
10.1016/j.pcd.2017.08.004
复制
发表时间：
2018-04-01
影响因子：
2.9
通讯作者：
Hamilton, Willie
中科院分区：
文献类型：
--
作者：
Hope, Suzy V.;Taylor, Phil J.;Hamilton, Willie
我们评估了已知低血糖的患者是否在其他场合出现与低血糖相关（但未诊断为）的非特异性症状，可能代表漏诊的低血糖。方法：对335例（5/2/12-4/2/13）bb0 ~ 65岁患者的初级保健记录（79例使用胰岛素，85例使用磺脲类药物，121例仅使用二甲双胍，50例无糖尿病）进行低血糖发作和非特异性症状（“低血糖线索”）就诊评估。结果：79例胰岛素治疗患者中有27例（34%）记录有低血糖发作，而4例磺胺脲治疗患者中有85例（5%），2例二甲双胍治疗患者中有121例（2%），无糖尿病患者，p 65年。在低血糖风险高的胰岛素治疗患者中，恶心、跌倒和不稳定应提示考虑低血糖。(C) 2017年作者。由爱思唯尔有限公司代表欧洲初级保健糖尿病出版。
Introduction: We assessed if patients with known hypoglycaemia present on other occasions with non-specific symptoms associated with (but not diagnosed as) hypoglycaemia, potentially representing missed hypoglycaemia.Methods: 335 primary care records (5/2/12-4/2/13) from patients aged >65 (79 on insulin, 85 on sulphonylureas, 121 on metformin only, 50 without diabetes) were assessed for hypoglycaemia episodes and consultations with non-specific symptoms, "hypo clues".Results: 27/79(34%) insulin-treated patients had >1 documented hypoglycaemia episode, compared to 4/85(5%) sulphonylurea-treated patients, 2/121(2%) metformin-only treated patients, and none without diabetes, p 65 years. In insulin-treated patients at high hypoglycaemia risk, nausea, falls and unsteadiness should prompt consideration of hypoglycaemia. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.